Beykin G, Stell L, Halim MS, Nunez M, et al. Corrigendum to Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes. Am J Ophthalmol 2022;234:223-234. Am J Ophthalmol 2022 Aug 14. pii: S0002-9394(22)00285.
PMID: 35977854